Article ID Journal Published Year Pages File Type
9974781 The Journal of Heart and Lung Transplantation 2005 4 Pages PDF
Abstract
Pravastatin therapy offers long-term benefits to heart transplant recipients. It improves 5-year survival, lowers the risk of transplant CAD, and lowers the incidence of hemodynamically significant rejection episodes.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Survival, Graft Atherosclerosis, and Rejection Incidence in Heart Transplant Recipients Treated With Statins: 5-Year Follow-up
Authors
, , , , , , ,